Trial: 202106015

Non-Randomized Phase 2 Trial of Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients with Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma



Principal Investigator

Adkins, Douglas

Disease Site

Lip, Oral Cavity and Pharynx; Unknown Sites

Learn more about this study at: